Eton Pharmaceuticals Reports Record Revenue and Earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Eton Pharmaceuticals Inc. (ETON) Reports Q1 EPS of $0.19
May 13, 2021 4:47 PM EDTEton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.19, versus ($0.50) reported last year. Revenue for the quarter came in at $11.9 million, versus $99 thousand reported last year.
For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.
... More